Results 171 to 180 of about 873,697 (316)
Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer
This study employed targeted metabolomic profiling to identify 302 distinct metabolites present in platelet‐rich plasma (PRP), revealing aberrant metabolic profiles amongst individuals diagnosed with colorectal cancer (CRC). Compared to carcinoembryonic antigen (CEA) and cancer antigen 19‐9 (CA199), our metabolite panel showed improved sensitivity ...
Zuojian Hu+7 more
wiley +1 more source
Effects of Ablation of the Submaxillary Gland in Guinea Pigs I
Kazuo Suzuki
openalex +2 more sources
Serum Growth Hormone Levels and the Response of Diabetic Retinopathy to Pituitary Ablation [PDF]
Alexander D. Wright+5 more
openalex +1 more source
Triacsin C inhibition of the acyl‐CoA synthetase long chain (ACSL) family decreases multiple myeloma cell survival, proliferation, mitochondrial respiration, and membrane potential. Made with Biorender.com. Multiple myeloma (MM) is an incurable cancer of plasma cells with a 5‐year survival rate of 59%.
Connor S. Murphy+12 more
wiley +1 more source
Mutants of bacteriophage lambda able to grow on the restricting hostEscherichia colistrain W [PDF]
S. W. Glover, J. Aronovitch
openalex +1 more source
Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer
mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia+17 more
wiley +1 more source
Detection of Incomplete Ablation After Yttrium-90 Implantation of Pituitary [PDF]
J. G. Sprunt+2 more
openalex +1 more source